NYSE · PG
The Procter & Gamble Company
$161.57+$0.98 (+0.61%)
The Procter & Gamble Company’s quoted price sits in the upper half of its reported 52-week range, 3.4% below the high.
Loading market information…
SIX · GALD.SW · CHF
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CHF. Historical prices are not a forecast.
Galderma Group AG’s quoted price sits in the upper half of its reported 52-week range, 0.54% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Galderma Group AG’s forward annual dividend is CHF 0.35 per share, paid annual. The forward yield is 0.18% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Galderma Group AG’s next earnings report is currently expected on Mar 11, 2027, with estimated earnings per share of CHF 2.12. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Galderma Group AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Latest available per-share figures in CHF. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 02:15 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2024 | Jul 25, 2024 | CHF 0.55-50.89% vs estimate | CHF 2.20B+11.18% vs estimate |
|---|
| Q1 2024 | May 7, 2024 | CHF 0.09 | CHF 997.90M |
|---|
| Q4 2023 | Mar 13, 2024 | -CHF 0.23 | CHF 1.75B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$161.57+$0.98 (+0.61%)
The Procter & Gamble Company’s quoted price sits in the upper half of its reported 52-week range, 3.4% below the high.
$109.23+$0.42 (+0.39%)
The Estée Lauder Companies Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.2% below the high.
€82.80+€2.06 (+2.55%)
Beiersdorf AG’s quoted price sits in the lower half of its reported 52-week range, 24.86% below the high.
€19.26+€0.36 (+1.9%)
Puig Brands S.A.’s quoted price sits in the upper half of its reported 52-week range, 2.53% below the high.
₹800.00-₹2.90 (-0.36%)
Marico Limited’s quoted price sits in the upper half of its reported 52-week range, 10.02% below the high.
₩261,000-₩21,500 (-7.61%)
APR Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.05% below the high.
$111.69-$1.26 (-1.12%)
e.l.f. Beauty, Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.64% below the high.
₩129,100+₩4,700 (+3.78%)
Amorepacific Corporation’s quoted price sits in the lower half of its reported 52-week range, 23.61% below the high.
